Identification of Corticomedullary Differentiation Along Different Stage of Pregnancy
Launched by MEIR MEDICAL CENTER · Jul 15, 2014
Trial Information
Current as of May 07, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • pregnant women 14-24 weeks
- • singleton pregnancy
- • Appropriate for gestational age fetuses
- • well dated pregnancy
- Exclusion Criteria:
- • family history of renal disease
- • small /large for gestational age fetuses
- • known structural anomalies
- • unknown dating
About Meir Medical Center
Meir Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a prominent sponsor of clinical studies, Meir Medical Center is committed to fostering collaboration among healthcare professionals, researchers, and patients to explore new therapies and treatment modalities. With a focus on ethical practices and patient safety, the center aims to contribute significantly to the scientific community while enhancing the quality of care provided to its diverse patient population. Through its robust infrastructure and multidisciplinary approach, Meir Medical Center stands at the forefront of medical innovation, driving progress in various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kfar Sava, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials